BioNexus Gene Lab Corp BGLCNasdaq
1.56USDClose on 08/10
At a glance
BioNexus Gene Lab Corp sits in the ‘Resting’ stage of its cycle. It has moved -67.6% since its first surge signal on 2025-11-18, when the past-year gain stood at +50.3%.
- Since surge signal
- -67.6%
- First surge signal
- 2025-11-18
- Price at signal
- 4.81
- Past-year gain (at signal)
- +50.3%
- Sector
- Materials
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.